Ted Snelgrove

Ted Snelgrove has extensive experience in the biotechnology and pharmaceutical industry. Ted is currently the Chief Executive Officer of FormaPath, Inc., a position they have held since March 2022. Prior to this, they worked as a Strategy Consultant from July 2020 to February 2022.

Before joining FormaPath, Ted served as the Chief Business Officer at Lexent Bio from March 2019 to June 2020. Ted was also the Chief Commercial Officer at Guardant Health from November 2017 to May 2018 and the Chief Business Officer at Counsyl from December 2015 to November 2017.

Ted has held leadership roles at various other organizations, including Jazz Pharmaceuticals, where they served as the Oncology/Hematology Business Unit Head from November 2014 to December 2015, and CellScape, where they were the Chief Executive Officer from July 2013 to March 2014.

Earlier in their career, Ted worked as the Chief Commercial Officer at Crescendo Bioscience from 2008 to 2013. Ted also served as the VP of Sales & Marketing at Genomic Health, Inc. from 2001 to 2008 and held roles in Business Planning & Oncology Marketing at ALZA Inc. from 1998 to 2001.

Ted Snelgrove holds an MBA in Marketing from the University of Michigan. Ted also obtained a BS in Economics from the University of Idaho. The specific start and end years for each degree are not provided.